138 related articles for article (PubMed ID: 33752475)
1. Integrated bioinformatic analysis of HNF1A in human cancers.
Zhang E; Huang X; He J
J Int Med Res; 2021 Mar; 49(3):300060521997326. PubMed ID: 33752475
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
Zhou X; Fan YH; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis for the role of CALR in human cancers.
Li Y; Liu X; Chen H; Xie P; Ma R; He J; Zhang H
PLoS One; 2021; 16(12):e0261254. PubMed ID: 34910788
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
5. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
7. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of
Haque E; Teeli AS; Winiarczyk D; Taguchi M; Sakuraba S; Kono H; Leszczyński P; Pierzchała M; Taniguchi H
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327967
[TBL] [Abstract][Full Text] [Related]
8. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.
Abel EV; Goto M; Magnuson B; Abraham S; Ramanathan N; Hotaling E; Alaniz AA; Kumar-Sinha C; Dziubinski ML; Urs S; Wang L; Shi J; Waghray M; Ljungman M; Crawford HC; Simeone DM
Elife; 2018 Aug; 7():. PubMed ID: 30074477
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of HNF1B mRNA in Human Cancers Based on Data Mining.
Nie C; Wang B; Wang B; Lv N; Zhang E
Int J Med Sci; 2020; 17(18):2895-2904. PubMed ID: 33173410
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
11. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
Farrelly AM; Wobser H; Bonner C; Anguissola S; Rehm M; Concannon CG; Prehn JH; Byrne MM
Diabetologia; 2009 Jan; 52(1):136-44. PubMed ID: 18949455
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
13. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
[TBL] [Abstract][Full Text] [Related]
14. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
[TBL] [Abstract][Full Text] [Related]
15. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HNF1A-AS1 upregulates OTX1 to enhance angiogenesis in colon cancer via the binding of transcription factor PBX3.
Wu J; Meng X; Jia Y; Chai J; Wang J; Xue X; Dang T
Exp Cell Res; 2020 Aug; 393(2):112025. PubMed ID: 32325080
[TBL] [Abstract][Full Text] [Related]
17. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice.
von Wnuck Lipinski K; Sattler K; Peters S; Weske S; Keul P; Klump H; Heusch G; Göthert JR; Levkau B
J Immunol; 2016 Feb; 196(4):1655-65. PubMed ID: 26800876
[TBL] [Abstract][Full Text] [Related]
19. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival.
Ma YF; Liang T; Li CR; Li YJ; Jin S; Liu Y
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4858-4863. PubMed ID: 27981551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
